Pharmaceutical
We represent individuals injured by hazardous pharmaceutical products. And we have been repeatedly selected by courts to leadership roles in precedent-setting, national pharmaceutical litigation. Our work has helped thousands of individuals harmed by dangerous pharmaceutical products obtain billions of dollars in relief.
Representative Cases
- We served as plaintiffs’ liaison counsel in multi-district litigation involving the Yaz and Yasmin hormonal contraceptives that resulted in a settlement of nearly $2 billion. In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL 2100)
- We served as co-lead counsel in the Pradaxa multi-district litigation that resulted in a $650 million nationwide settlement. In re: Pradaxa (Dabigatran) Products Liability Litigation (MDL 2385)
- We served as lead counsel and lead negotiator in the NuvaRing litigation that resulted in a $100 million global settlement. In re: NuvaRing Products Liability Litigation (MDL 1964)
Results & Recognition

Announcing the Release of Volume II, Issue III of Schlichter Bogard & Denton’s Railroad Injury Newsletter
Schlichter Bogard & Denton is pleased to announce the release of Volume II, Issue III…
Read More
Schlichter Bogard & Denton Achieves National Recognition from Chambers and Partners
Schlichter Bogard & Denton has been selected by Chambers and Partners, one of the world’s…
Read More